Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Masashi Mizuno Yasuhiko Ito Akio Tanaka Yasuhiro Suzuki Hideki Hiramatsu Midoriko Watanabe Yoshikazu Tsuruta Teppei Matsuoka Isao Ito
- چاپ و سال / کشور: 2011
Description
Background In Japan, the population of patients on peritoneal dialysis (PD) is\4% of the total number of patients with end-stage renal disease. Few systemic analyses have examined why the number of PD patients has not increased in Japan. We organized a registry to analyze PD patients and retrospectively investigated 561 PD patients (about 5% of all Japanese PD patients) from 13 hospitals in the Tokai area for 3 years from 2005. Methods We investigated background, physical status, laboratory data, status of PD therapy, and the occurrence of PD-related complications, and analyzed reasons for withdrawal from PD. Results Nutrition did not change significantly during our observation. Urinary volume showed continued decreases after the introduction period. In contrast, PD fluid demand and ultrafiltration volume were significantly increased. For calcium metabolism, multiple phosphate binders were required after the second year of PD therapy. Early dropout within 3 years after starting PD therapy comprised 50.9% of total withdrawals, with PD-related peritonitis as the most common reason, mainly caused by Gram-positive organisms. Incidence of peritonitis was 42.8 months/ patient. Culture-negative results were obtained for 32% of peritonitis cultures. Diabetes affects the prognosis of PD therapy, but not the incidence of peritonitis.Conclusion We examined clinical status over 3 years in the Tokai area. The results suggest that the incidence of peritonitis needs to be decreased to prevent early withdrawal of PD patients. Education systems to decrease the incidence of peritonitis and techniques to decrease culturenegative results might be important for improving the prognosis of peritonitis.
Clin Exp Nephrol DOI 10.1007/s10157-011-0471-8 Received: 19 January 2011 / Accepted: 25 May 2011
